Cargando…
Safety and Efficacy of Drug-Coated Balloons in Patients with Acute Coronary Syndromes and Vulnerable Plaque
BACKGROUND: Percutaneous coronary intervention (PCI) is the main treatment option for acute coronary syndromes (ACS) often related to the progression and rupture of vulnerable plaques. While drug-eluting stents (DES) are now routinely used in PCI, drug-coated balloons (DCB) are a new strategy to PCI...
Autores principales: | Zhang, Yu-Bin, Liu, Heng-Dao, Xing, Jun-Hui, Chen, Bo-Wen, Zhao, Yan-Yan, Gu, He-Ping, Tao, Hai-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537494/ https://www.ncbi.nlm.nih.gov/pubmed/36198017 http://dx.doi.org/10.1177/10760296221130063 |
Ejemplares similares
-
The Drug Coated Balloon-Only Strategy for Treatment of de Novo Left
Main Coronary Artery Bifurcation Lesion: Stentless Strategy
por: Liu, Hengdao, et al.
Publicado: (2022) -
Analysis of the Correlation Between the Ratio of Monocytes to
High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with
Premature Coronary Heart Disease
por: Chen, Bo-Wen, et al.
Publicado: (2022) -
Prevalence, Morphology, and Predictors of Intra-Stent Plaque Rupture in Patients with Acute Coronary Syndrome: An Optical Coherence Tomography Study
por: Yu, Huai, et al.
Publicado: (2022) -
Safety and Efficacy of an Innovative Everolimus-Coated Balloon in a Swine Coronary Artery Model
por: Katsouras, Christos S., et al.
Publicado: (2023) -
The Efficacy of Drug-Coated Balloon for Acute Coronary Syndrome
por: Naganawa, Hirokazu, et al.
Publicado: (2023)